Literature DB >> 16360044

Significance of QRS complex duration in patients with heart failure.

Amir Kashani1, S Serge Barold.   

Abstract

Prolongation of QRS (> or =120 ms) occurs in 14% to 47% of heart failure (HF) patients. Left bundle branch block is far more common than right bundle branch block. Left-sided intraventricular conduction delay is associated with more advanced myocardial disease, worse left ventricular (LV) function, poorer prognosis, and a higher all-cause mortality rate compared with narrow QRS complex. It also predisposes heart failure patients to an increased risk of ventricular tachyarrhythmias, but the incidence of cardiac or sudden death remains unclear because of limited observations. A progressive increase in QRS duration worsens the prognosis. No electrocardiographic measure is specific enough to provide subgroup risk categorization for excluding or selecting HF patients for prophylactic implantable cardioverter-defibrillator (ICD) therapy. In ICD patients with HF, a wide underlying QRS complex more than doubles the cardiac mortality compared with a narrow QRS complex. There is a high incidence of an elevated defibrillation threshold at the time of ICD implantation in patients with QRS > or =200 ms. Mechanical LV dyssynchrony potentially treatable by ventricular resynchronization occurs in about 70% of HF patients with left-sided intraventricular conduction delay, a fact that would explain the lack of therapeutic response in about 30% of patients subjected to ventricular resynchronization according to standard criteria relying on QRS duration. The duration of the basal QRS complex does not reliably predict the clinical response to ventricular resynchronization, and QRS narrowing after cardiac resynchronization therapy does not correlate with hemodynamic and clinical improvement. Mechanical LV dyssynchrony is best shown by evolving echocardiographic techniques (predominantly tissue Doppler imaging) currently in the process of standardization.

Entities:  

Mesh:

Year:  2005        PMID: 16360044     DOI: 10.1016/j.jacc.2005.01.071

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  89 in total

Review 1.  Cardiac resynchronization therapy in patients with a narrow QRS.

Authors:  Johannes Holzmeister; David Hürlimann; Jan Steffel; Frank Ruschitzka
Journal:  Curr Heart Fail Rep       Date:  2009-03

2.  Influence of QRS duration and axis on response to cardiac resynchronization therapy in chronic heart failure with reduced left ventricular ejection fraction: A single center study including patients with left bundle branch block.

Authors:  Tomasz Fabiszak; Piotr Łach; Jakub Ratajczak; Marek Koziński; Wojciech Krupa; Jacek Kubica
Journal:  Cardiol J       Date:  2018-11-16       Impact factor: 2.737

Review 3.  An updated review of cardiac devices in heart failure.

Authors:  C Murphy; H Zafar; F Sharif
Journal:  Ir J Med Sci       Date:  2017-03-25       Impact factor: 1.568

Review 4.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

5.  Reduced Arrhythmia Inducibility With Calcium/Calmodulin-dependent Protein Kinase II Inhibition in Heart Failure Rabbits.

Authors:  Gregory S Hoeker; Mohamed A Hanafy; Robert A Oster; Donald M Bers; Steven M Pogwizd
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

6.  Significance of signal averaged electrocardiography in patients with advanced heart failure and intraventricular conduction delay.

Authors:  Mohammad Alasti; Majid Haghjoo; Abolfath Alizadeh; Mohammad Hossein Nikoo; Hamid Reza Bonakdar; Bita Omidvar; Ali Kharazi; Bahman Cheraghian
Journal:  Indian Pacing Electrophysiol J       Date:  2010-05-05

7.  Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β.

Authors:  Jonathan A Kirk; Ronald J Holewinski; Viola Kooij; Giulio Agnetti; Richard S Tunin; Namthip Witayavanitkul; Pieter P de Tombe; Wei Dong Gao; Jennifer Van Eyk; David A Kass
Journal:  J Clin Invest       Date:  2014-01       Impact factor: 14.808

8.  Electrocardiographic left ventricular hypertrophy Cornell product is a feasible predictor of cardiac prognosis in patients with chronic heart failure.

Authors:  Yoichiro Otaki; Hiroki Takahashi; Tetsu Watanabe; Shinpei Kadowaki; Taro Narumi; Yuki Honda; Hiromasa Hasegawa; Shintaro Honda; Akira Funayama; Satoshi Nishiyama; Takanori Arimoto; Tetsuro Shishido; Takehiko Miyashita; Takuya Miyamoto; Isao Kubota
Journal:  Clin Res Cardiol       Date:  2013-12-01       Impact factor: 5.460

9.  QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.

Authors:  Matthew G Whitbeck; Richard J Charnigo; Jignesh Shah; Gustavo Morales; Steve W Leung; Brandon Fornwalt; Alison L Bailey; Khaled Ziada; Vincent L Sorrell; Milagros M Zegarra; Jenks Thompson; Neil Aboul Hosn; Charles L Campbell; John Gurley; Paul Anaya; David C Booth; Luigi Di Biase; Andrea Natale; Susan Smyth; David J Moliterno; Claude S Elayi
Journal:  Europace       Date:  2013-12-23       Impact factor: 5.214

10.  Genome-wide association study of electrocardiographic conduction measures in an isolated founder population: Kosrae.

Authors:  J Gustav Smith; Jennifer K Lowe; Sirisha Kovvali; Julian B Maller; Jacqueline Salit; Mark J Daly; Markus Stoffel; David M Altshuler; Jeffrey M Friedman; Jan L Breslow; Christopher Newton-Cheh
Journal:  Heart Rhythm       Date:  2009-02-15       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.